Safety and antiemetic effects of metoclopramide in metrizamide myelography.
D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*; D008793:Metrizamide / Q000009:adverse effects*; D009192:Myelography; D009325:Nausea / Q000517:prevention & control*; D010919:Placebos; D011897:Random Allocation; D012449:Safety; D014839:Vomiting / Q000517:prevention & control*
D010919:Placebos; D008787:Metoclopramide; D008793:Metrizamide